Archive | ARTES Biotechnology GmbH

Page 1 of 5
54490ARTES recombinant antigens, proteins, and enzymes
ARTES recombinant antigens, proteins, and enzymes Learn More >
ARTES announce expansion of the management board
ARTES announce expansion of the management board Learn More >
ARTES adds direct reagent sales for laboratories
ARTES adds direct reagent sales for laboratories Learn More >
ARTES presenting innovative vaccine technologies at BIO-Europe Munich
ARTES presenting innovative vaccine technologies at BIO-Europe Munich Learn More >
ARTES partners with Basic Pharma to advance recombinant protein production
ARTES partners with Basic Pharma to advance recombinant protein production Learn More >
ARTES to present innovative microbial expression technologies for API development at European Pharma Partnering Summit
ARTES to present innovative microbial expression technologies for API development at European Pharma Partnering Summit Learn More >
ARTES sponsors 6th BioProcessingDays conference
ARTES sponsors 6th BioProcessingDays conference Learn More >
52042ARTES heterologous production of holoproteins in Hansenula polymorpha yeast
ARTES heterologous production of holoproteins in Hansenula polymorpha yeast Learn More >
Heterologous production of holoproteins in Hansenula polymorpha
Heterologous production of holoproteins in Hansenula polymorpha Learn More >
Strain Construction and Process Development for Efficient Recombinant Production of Mannuronan C-5 Epimerases in Hansenula polymorpha
Strain Construction and Process Development for Efficient Recombinant Production of Mannuronan C-5 Epimerases in Hansenula polymorpha Learn More >
ARTES 20th Year Anniversary – a short overview
ARTES 20th Year Anniversary – a short overview Learn More >
ARTES and Cellumed accelerate development of key GMP-grade production enzymes needed for mRNA-based biopharmaceuticals
ARTES and Cellumed accelerate development of key GMP-grade production enzymes needed for mRNA-based biopharmaceuticals Learn More >
Page 1 of 5